Kamada (KMDA) Free Cash Flow Growth (3y) (2015 - 2026)
Kamada (KMDA) Free Cash Flow Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 9.86% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | -18.92% |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | -44.64% |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | 0.68% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | -27.74% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 46.56% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 39.19% |
| 10 | Kamada | 400.07 Mn | 326.92 Mn | 19.12 Mn | 633.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 633.92% |
| Dec 31, 2025 | 72.43% |
| Sep 30, 2025 | 1,153.66% |
| Jun 30, 2025 | -0.25% |
| Mar 31, 2025 | -45.74% |
| Dec 31, 2024 | 125.22% |
| Sep 30, 2024 | 185.13% |
| Jun 30, 2024 | 120.45% |
| Mar 31, 2024 | 18.35% |
| Dec 31, 2023 | -28.37% |
| Sep 30, 2023 | -11.73% |
| Jun 30, 2023 | -37.50% |
| Mar 31, 2023 | 88.08% |
| Dec 31, 2022 | -53.00% |
| Sep 30, 2022 | -89.86% |
| Jun 30, 2022 | 11.94% |
| Mar 31, 2022 | -2.07% |
| Dec 31, 2021 | -53.23% |
| Sep 30, 2021 | -39.76% |
| Jun 30, 2021 | -22.26% |